Ici-refractory

Clinical trials for Ici-refractory explained in plain language.

Never miss a new study

Get alerted when new Ici-refractory trials appear

Sign up with your email to follow new studies for Ici-refractory, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for tough lung cancers: experimental drug targets immunotherapy failures

Disease control Recruiting now

This phase 2 trial tests whether the experimental drug SAR445877 can help control advanced non-small cell lung cancer in people whose tumors no longer respond to immunotherapy. About 29 adults with locally advanced or metastatic disease will receive the drug by IV. The main goal …

Matched conditions: ICI-REFRACTORY

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC

Ici-refractory

Get alerted when new Ici-refractory trials appear

New hope for tough lung cancers: experimental drug targets immunotherapy failures